Drug Side Effects

LEVOFLOXACIN

LEVOFLOXACIN was reported 43628 times

LEVOFLOXACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL HIATUS HERNIA 36 0.6667
1 MITE ALLERGY 108 0.3600
2 SPIROMETRY ABNORMAL 108 0.3176
3 SEDATION COMPLICATION 375 0.2390
4 MYCOTIC ALLERGY 110 0.2263
5 DUST ALLERGY 110 0.2095
6 DISSEMINATED MUCORMYCOSIS 27 0.1875
7 TENDON DISCOMFORT 87 0.1638
8 PULMONARY VASCULITIS 34 0.1504
9 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 30 0.1382
10 TENDON PAIN 783 0.1314
11 DYSBIOSIS 42 0.1277
12 CONJUNCTIVITIS ALLERGIC 115 0.1230
13 CREATININE RENAL CLEARANCE DECREASED 372 0.1075
14 CRYSTAL NEPHROPATHY 38 0.1041
15 CONTRAST MEDIA ALLERGY 95 0.0936
16 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 81 0.0849
17 TENDON DISORDER 428 0.0823
18 TYPE I HYPERSENSITIVITY 179 0.0808
19 COMPUTERISED TOMOGRAM THORAX ABNORMAL 48 0.0784
20 REBOUND ACID HYPERSECRETION 228 0.0779
21 NEPHROGENIC ANAEMIA 327 0.0763
22 BLOODY DISCHARGE 66 0.0745
23 EOSINOPHILIC PNEUMONIA ACUTE 30 0.0686
24 HYPERPARATHYROIDISM SECONDARY 155 0.0684
25 TENDONITIS 820 0.0649
26 STENOTROPHOMONAS INFECTION 58 0.0648
27 HYPOCOAGULABLE STATE 51 0.0634
28 PATHOGEN RESISTANCE 396 0.0629
29 FUSARIUM INFECTION 27 0.0624
30 SPUTUM PURULENT 33 0.0619
31 TENDON RUPTURE 582 0.0571
32 THERAPEUTIC PRODUCT CROSS-REACTIVITY 50 0.0545
33 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 30 0.0541
34 INTERNATIONAL NORMALISED RATIO FLUCTUATION 100 0.0508
35 NORMOCHROMIC NORMOCYTIC ANAEMIA 119 0.0489
36 BLOOD CALCIUM DECREASED 416 0.0459
37 OBLITERATIVE BRONCHIOLITIS 50 0.0458
38 NEURITIS 49 0.0447
39 URINARY TRACT INFECTION ENTEROCOCCAL 35 0.0434
40 END STAGE RENAL DISEASE 683 0.0424
41 VASCULAR PURPURA 44 0.0423
42 PSEUDOMEMBRANOUS COLITIS 78 0.0409
43 NORMOCYTIC ANAEMIA 33 0.0394
44 JOINT NOISE 43 0.0386
45 ENTEROCOCCAL BACTERAEMIA 27 0.0379
46 FIXED ERUPTION 36 0.0363
47 ORTHOSTATIC HYPOTENSION 491 0.0359
48 PNEUMONIA LEGIONELLA 41 0.0335
49 KOUNIS SYNDROME 47 0.0332
50 CHRONIC KIDNEY DISEASE 2179 0.0325
51 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 552 0.0313
52 PNEUMONIA FUNGAL 74 0.0304
53 RESPIRATORY ALKALOSIS 36 0.0302
54 ACUTE MYELOID LEUKAEMIA RECURRENT 37 0.0295
55 DERMATITIS EXFOLIATIVE GENERALISED 58 0.0294
56 LONG QT SYNDROME 54 0.0292
57 FUNGAEMIA 33 0.0291
58 CHRONIC FATIGUE SYNDROME 29 0.0290
59 MALIGNANT MELANOMA IN SITU 31 0.0287
60 JOINT CREPITATION 57 0.0287
61 EOSINOPHILIC PNEUMONIA 59 0.0275
62 FULL BLOOD COUNT ABNORMAL 142 0.0273
63 OPTIC NEUROPATHY 42 0.0270
64 PALATAL OEDEMA 27 0.0268
65 MUCORMYCOSIS 49 0.0268
66 TORSADE DE POINTES 164 0.0261
67 RESPIRATORY SYMPTOM 38 0.0260
68 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 171 0.0259
69 BRONCHIAL OBSTRUCTION 30 0.0258
70 HEPATIC CYTOLYSIS 73 0.0256
71 CYTOKINE RELEASE SYNDROME 161 0.0255
72 TENDON INJURY 78 0.0255
73 MEGACOLON 30 0.0251
74 CHOREA 33 0.0247
75 BRONCHOPULMONARY ASPERGILLOSIS 135 0.0245
76 TOXIC EPIDERMAL NECROLYSIS 276 0.0245
77 LYME DISEASE 61 0.0244
78 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 46 0.0242
79 LIP OEDEMA 79 0.0239
80 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 93 0.0238
81 WEIGHT BEARING DIFFICULTY 50 0.0236
82 SEDATION 440 0.0234
83 TUBULOINTERSTITIAL NEPHRITIS 328 0.0233
84 CYTOMEGALOVIRUS INFECTION REACTIVATION 35 0.0232
85 PLANTAR FASCIITIS 57 0.0228
86 CYTOMEGALOVIRUS TEST POSITIVE 31 0.0227
87 PULMONARY ALVEOLAR HAEMORRHAGE 85 0.0221
88 CLOSTRIDIUM DIFFICILE COLITIS 178 0.0220
89 NOCARDIOSIS 39 0.0220
90 LINEAR IGA DISEASE 27 0.0213
91 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 97 0.0206
92 ENTEROCOCCAL INFECTION 72 0.0206
93 SPUTUM INCREASED 29 0.0205
94 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 33 0.0199
95 PERIPHERAL VENOUS DISEASE 31 0.0199
96 LUNG CONSOLIDATION 44 0.0198
97 RENAL TUBULAR NECROSIS 149 0.0198
98 OTOTOXICITY 27 0.0197
99 FEBRILE NEUTROPENIA 928 0.0197
100 ATELECTASIS 156 0.0195
101 ACUTE KIDNEY INJURY 2070 0.0190
102 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 59 0.0189
103 BILIRUBIN CONJUGATED INCREASED 35 0.0187
104 BREATH SOUNDS ABNORMAL 65 0.0187
105 APLASTIC ANAEMIA 75 0.0186
106 BRONCHIECTASIS 82 0.0184
107 CLOSTRIDIAL INFECTION 57 0.0183
108 HISTIOCYTOSIS HAEMATOPHAGIC 55 0.0182
109 MYOCLONUS 173 0.0182
110 FORCED EXPIRATORY VOLUME DECREASED 38 0.0182
111 KLEBSIELLA INFECTION 64 0.0181
112 DRUG RESISTANCE 333 0.0180
113 BENIGN PROSTATIC HYPERPLASIA 76 0.0180
114 ELECTROCARDIOGRAM QT PROLONGED 484 0.0179
115 BRONCHITIS CHRONIC 37 0.0179
116 BRAIN ABSCESS 32 0.0179
117 DEPRESSED LEVEL OF CONSCIOUSNESS 548 0.0178
118 CONJUNCTIVAL HYPERAEMIA 47 0.0177
119 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 105 0.0176
120 MIXED LIVER INJURY 27 0.0175
121 MUCOSAL DRYNESS 27 0.0174
122 NEUROTOXICITY 206 0.0174
123 HYPERSENSITIVITY VASCULITIS 43 0.0172
124 CYSTIC FIBROSIS 78 0.0172
125 MULTIPLE-DRUG RESISTANCE 31 0.0172
126 WALKING DISABILITY 29 0.0171
127 QUADRIPLEGIA 28 0.0171
128 HYPERPYREXIA 44 0.0168
129 HYPOXIA 440 0.0168
130 PARADOXICAL DRUG REACTION 44 0.0168
131 TONGUE OEDEMA 51 0.0167
132 PSEUDOMONAS INFECTION 99 0.0165
133 COGNITIVE DISORDER 580 0.0164
134 RHINOVIRUS INFECTION 32 0.0163
135 GUILLAIN-BARRE SYNDROME 57 0.0162
136 MUSCLE CONTRACTURE 27 0.0162
137 CYSTITIS HAEMORRHAGIC 49 0.0162
138 FOOD INTOLERANCE 42 0.0161
139 DUODENITIS 39 0.0160
140 AORTIC ANEURYSM 102 0.0159
141 HYPOGLYCAEMIC COMA 37 0.0159
142 EOSINOPHILIA 204 0.0158
143 ASPERGILLUS INFECTION 69 0.0158
144 DRUG-INDUCED LIVER INJURY 287 0.0156
145 ENTEROCOLITIS 59 0.0155
146 HEPATITIS TOXIC 33 0.0154
147 ACUTE GRAFT VERSUS HOST DISEASE 55 0.0154
148 MULTIPLE ORGAN DYSFUNCTION SYNDROME 266 0.0153
149 TOXIC ENCEPHALOPATHY 52 0.0153
150 CHOLESTASIS 217 0.0152
151 RASH MORBILLIFORM 32 0.0152
152 BACTERIAL TEST POSITIVE 27 0.0152
153 HYPERTRANSAMINASAEMIA 44 0.0149
154 CHRONIC SINUSITIS 38 0.0148
155 SEPTIC SHOCK 463 0.0147
156 HEPATOSPLENOMEGALY 31 0.0146
157 TOXIC SKIN ERUPTION 113 0.0145
158 RENAL INJURY 399 0.0145
159 CLOSTRIDIUM DIFFICILE INFECTION 221 0.0145
160 LOSS OF EMPLOYMENT 39 0.0143
161 ARTERIOSCLEROSIS 110 0.0143
162 HEPATITIS CHOLESTATIC 65 0.0142
163 BLOOD BILIRUBIN INCREASED 311 0.0141
164 RENAL FAILURE 1603 0.0141
165 PNEUMONIA BACTERIAL 82 0.0141
166 COVID-19 PNEUMONIA 100 0.0140
167 RASH MACULO-PAPULAR 229 0.0140
168 BACTERAEMIA 117 0.0140
169 HEPATIC NECROSIS 45 0.0139
170 EYE INJURY 29 0.0139
171 HYPERBILIRUBINAEMIA 107 0.0139
172 ESCHERICHIA INFECTION 80 0.0137
173 HEPATITIS FULMINANT 33 0.0137
174 PNEUMOCYSTIS JIROVECII PNEUMONIA 90 0.0135
175 EXERCISE TOLERANCE DECREASED 58 0.0135
176 ENDOPHTHALMITIS 58 0.0134
177 OBSTRUCTIVE AIRWAYS DISORDER 114 0.0134
178 ACUTE PSYCHOSIS 26 0.0134
179 MUSCLE ATROPHY 120 0.0134
180 PURPURA 95 0.0133
181 HYDROCEPHALUS 57 0.0132
182 HYPERURICAEMIA 42 0.0132
183 MUCOSAL INFLAMMATION 261 0.0132
184 BACTERIAL SEPSIS 33 0.0132
185 PULMONARY TUBERCULOSIS 46 0.0132
186 ACUTE MYELOID LEUKAEMIA 154 0.0132
187 HYPOALBUMINAEMIA 73 0.0132
188 MUSCLE RUPTURE 38 0.0131
189 CHOLANGITIS 56 0.0131
190 DELIRIUM 332 0.0131
191 HYPOMAGNESAEMIA 128 0.0131
192 SPUTUM DISCOLOURED 89 0.0130
193 ACUTE RESPIRATORY DISTRESS SYNDROME 176 0.0128
194 CHRONIC GRAFT VERSUS HOST DISEASE 34 0.0127
195 ARTERIOSCLEROSIS CORONARY ARTERY 66 0.0127
196 AORTIC DISSECTION 44 0.0125
197 CYTOMEGALOVIRUS VIRAEMIA 34 0.0124
198 OLIGURIA 62 0.0124
199 NEUROPATHY PERIPHERAL 830 0.0124
200 HAEMATOTOXICITY 74 0.0123
201 NODULE 119 0.0123
202 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 38 0.0123
203 POLYNEUROPATHY 102 0.0122
204 BLOOD CHLORIDE DECREASED 27 0.0121
205 GRAFT VERSUS HOST DISEASE 70 0.0121
206 PROTEIN TOTAL DECREASED 35 0.0119
207 VENTRICULAR ARRHYTHMIA 34 0.0118
208 MUSCLE CONTRACTIONS INVOLUNTARY 34 0.0118
209 PNEUMONITIS 220 0.0118
210 ESCHERICHIA SEPSIS 27 0.0117
211 HAEMODYNAMIC INSTABILITY 62 0.0117
212 THROMBOTIC MICROANGIOPATHY 76 0.0117
213 DERMATITIS BULLOUS 65 0.0117
214 DYSAESTHESIA 27 0.0116
215 PRODUCTIVE COUGH 378 0.0116
216 PERIPHERAL SENSORY NEUROPATHY 49 0.0115
217 HEPATOTOXICITY 184 0.0115
218 CHEST X-RAY ABNORMAL 31 0.0115
219 ENCEPHALOPATHY 207 0.0114
220 PANCYTOPENIA 475 0.0114
221 NEUROLOGICAL SYMPTOM 49 0.0114
222 BLOOD CULTURE POSITIVE 31 0.0113
223 BLOOD LACTATE DEHYDROGENASE INCREASED 151 0.0113
224 HYPOKALAEMIA 392 0.0113
225 VENTRICULAR HYPOKINESIA 29 0.0112
226 STATUS EPILEPTICUS 98 0.0112
227 INTERNATIONAL NORMALISED RATIO INCREASED 297 0.0112
228 DRUG ERUPTION 143 0.0112
229 STAPHYLOCOCCAL SEPSIS 46 0.0112
230 ANAPHYLACTOID REACTION 36 0.0109
231 INFLAMMATORY MARKER INCREASED 33 0.0109
232 ACUTE RESPIRATORY FAILURE 150 0.0109
233 RESPIRATORY ACIDOSIS 31 0.0109
234 ASPARTATE AMINOTRANSFERASE INCREASED 465 0.0109
235 AFFECTIVE DISORDER 63 0.0109
236 STAPHYLOCOCCAL BACTERAEMIA 33 0.0108
237 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 35 0.0107
238 CANDIDA INFECTION 124 0.0107
239 LARYNGEAL OEDEMA 52 0.0107
240 BRONCHOPNEUMONIA 36 0.0105
241 RESPIRATORY FAILURE 603 0.0104
242 VENOOCCLUSIVE LIVER DISEASE 37 0.0104
243 NEPHROPATHY TOXIC 79 0.0103
244 DISSEMINATED INTRAVASCULAR COAGULATION 120 0.0103
245 VASCULITIS 87 0.0103
246 LYMPHOCYTE COUNT DECREASED 138 0.0102
247 PNEUMOTHORAX 121 0.0102
248 ALANINE AMINOTRANSFERASE INCREASED 497 0.0101
249 C-REACTIVE PROTEIN INCREASED 262 0.0100
250 CYTOMEGALOVIRUS INFECTION 125 0.0100
251 AZOTAEMIA 30 0.0100
252 TUMOUR LYSIS SYNDROME 61 0.0100
253 MOBILITY DECREASED 527 0.0100
254 AGRANULOCYTOSIS 126 0.0099
255 ANHEDONIA 234 0.0099
256 LUNG INFECTION 154 0.0099
257 VENTRICULAR TACHYCARDIA 125 0.0098
258 THROMBOCYTOPENIA 814 0.0097
259 ERYTHEMA MULTIFORME 72 0.0097
260 METABOLIC ACIDOSIS 221 0.0097
261 TRANSAMINASES INCREASED 170 0.0097
262 OESOPHAGEAL CANDIDIASIS 28 0.0096
263 ROTATOR CUFF SYNDROME 99 0.0096
264 HYPOGLYCAEMIA 374 0.0096
265 ECONOMIC PROBLEM 139 0.0095
266 TUBERCULOSIS 92 0.0095
267 ACUTE HEPATIC FAILURE 93 0.0094
268 URINE OUTPUT DECREASED 68 0.0094
269 PROTHROMBIN TIME PROLONGED 51 0.0094
270 PNEUMONIA 2233 0.0094
271 LEFT VENTRICULAR DYSFUNCTION 48 0.0094
272 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 269 0.0093
273 BONE LESION 26 0.0093
274 CYTOLYTIC HEPATITIS 31 0.0093
275 HEPATITIS ACUTE 47 0.0093
276 SKIN TOXICITY 33 0.0093
277 BLOOD ALKALINE PHOSPHATASE INCREASED 194 0.0093
278 DRUG INTERACTION 1155 0.0093
279 NEPHROPATHY 72 0.0092
280 CACHEXIA 37 0.0092
281 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 40 0.0092
282 IRON DEFICIENCY 27 0.0092
283 RESPIRATORY DISTRESS 202 0.0092
284 BLOOD URIC ACID INCREASED 38 0.0092
285 VENTRICULAR FIBRILLATION 82 0.0091
286 ORAL CANDIDIASIS 86 0.0091
287 PETECHIAE 74 0.0091
288 LEUKOCYTOSIS 126 0.0091
289 HAEMOPTYSIS 202 0.0090
290 LEUKOPENIA 342 0.0090
291 BACTERIAL INFECTION 119 0.0090
292 ORGANISING PNEUMONIA 30 0.0090
293 TACHYPNOEA 89 0.0090
294 WHEEZING 367 0.0090
295 DRUG HYPERSENSITIVITY 1391 0.0090
296 HEPATIC FUNCTION ABNORMAL 240 0.0090
297 BLOOD UREA INCREASED 128 0.0090
298 UPPER RESPIRATORY TRACT INFECTION 303 0.0089
299 STEVENS-JOHNSON SYNDROME 164 0.0089
300 BALANCE DISORDER 613 0.0089
301 HYPERNATRAEMIA 33 0.0088
302 RESPIRATORY TRACT INFECTION 159 0.0088
303 RALES 40 0.0088
304 COMPRESSION FRACTURE 30 0.0087
305 MULTI-ORGAN FAILURE 150 0.0086
306 SEPSIS 744 0.0086
307 MENTAL STATUS CHANGES 192 0.0085
308 GAMMA-GLUTAMYLTRANSFERASE INCREASED 159 0.0085
309 FAILURE TO THRIVE 37 0.0085
310 MUSCLE TIGHTNESS 110 0.0085
311 HYPOVOLAEMIC SHOCK 31 0.0085
312 NEUTROPHIL COUNT DECREASED 238 0.0085
313 CANDIDIASIS 34 0.0085
314 BLOOD ALBUMIN DECREASED 53 0.0084
315 STAPHYLOCOCCAL INFECTION 226 0.0084
316 LUNG INFILTRATION 66 0.0084
317 NEUTROPENIA 790 0.0083
318 PYELONEPHRITIS 54 0.0083
319 JOINT RANGE OF MOTION DECREASED 70 0.0083
320 FACE OEDEMA 112 0.0083
321 HYPOPHOSPHATAEMIA 44 0.0082
322 CARDIAC FAILURE ACUTE 39 0.0082
323 MUSCULOSKELETAL PAIN 383 0.0082
324 CHOLECYSTITIS ACUTE 37 0.0082
325 IMPAIRED WORK ABILITY 145 0.0082
326 ANURIA 59 0.0082
327 ENDOCARDITIS 32 0.0082
328 BLOOD COUNT ABNORMAL 127 0.0081
329 PYREXIA 2160 0.0081
330 ODYNOPHAGIA 35 0.0081
331 HOSPICE CARE 50 0.0081
332 GENERALISED ERYTHEMA 46 0.0081
333 DERMATITIS EXFOLIATIVE 37 0.0080
334 ILEUS PARALYTIC 27 0.0080
335 HEPATOCELLULAR INJURY 99 0.0079
336 PULMONARY FIBROSIS 106 0.0079
337 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 59 0.0079
338 GASTRITIS EROSIVE 31 0.0079
339 NEUTROPHIL COUNT INCREASED 63 0.0078
340 PULMONARY HAEMORRHAGE 51 0.0078
341 STREPTOCOCCAL INFECTION 30 0.0078
342 HYPERAMMONAEMIA 29 0.0078
343 NEURALGIA 138 0.0078
344 ENTERITIS 34 0.0078
345 HAEMATOMA 167 0.0077
346 PERIPHERAL COLDNESS 83 0.0077
347 PULMONARY TOXICITY 35 0.0077
348 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 312 0.0077
349 GINGIVITIS 33 0.0077
350 PLEURAL EFFUSION 370 0.0077
351 ERYSIPELAS 30 0.0077
352 HALLUCINATION, VISUAL 114 0.0076
353 CYTOPENIA 50 0.0076
354 ECCHYMOSIS 43 0.0076
355 ABDOMINAL TENDERNESS 30 0.0075
356 UROSEPSIS 52 0.0075
357 SINUS TACHYCARDIA 84 0.0075
358 HEPATITIS 147 0.0074
359 HYPOTENSION 1147 0.0074
360 BLOOD CREATININE INCREASED 387 0.0074
361 SUPRAVENTRICULAR TACHYCARDIA 57 0.0074
362 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 56 0.0074
363 ALTERED STATE OF CONSCIOUSNESS 114 0.0074
364 PLEURISY 37 0.0073
365 BURSITIS 57 0.0073
366 GASTROOESOPHAGEAL REFLUX DISEASE 444 0.0073
367 NEUTROPENIC SEPSIS 42 0.0073
368 JOINT EFFUSION 40 0.0072
369 PLATELET COUNT DECREASED 579 0.0072
370 MALNUTRITION 59 0.0072
371 OSTEOPENIA 88 0.0072
372 GASTROENTERITIS 81 0.0072
373 RESPIRATORY DISORDER 165 0.0072
374 INTERSTITIAL LUNG DISEASE 253 0.0072
375 HICCUPS 44 0.0072
376 RENAL FAILURE ACUTE 305 0.0072
377 RHABDOMYOLYSIS 233 0.0071
378 PROTEIN URINE PRESENT 27 0.0071
379 VITREOUS FLOATERS 49 0.0071
380 NERVOUS SYSTEM DISORDER 189 0.0071
381 ILEUS 66 0.0071
382 OESOPHAGITIS 61 0.0071
383 HIATUS HERNIA 76 0.0071
384 HEPATIC ENCEPHALOPATHY 53 0.0071
385 HYPERTHERMIA 43 0.0071
386 OEDEMA 289 0.0071
387 INTESTINAL ISCHAEMIA 30 0.0071
388 AUTOIMMUNE HEPATITIS 35 0.0071
389 MENINGITIS 36 0.0071
390 HAEMOLYTIC ANAEMIA 51 0.0071
391 GENERALISED TONIC-CLONIC SEIZURE 80 0.0070
392 CORONARY ARTERY STENOSIS 30 0.0070
393 GENERALISED OEDEMA 64 0.0070
394 COAGULOPATHY 94 0.0069
395 RENAL IMPAIRMENT 427 0.0069
396 EOSINOPHIL COUNT INCREASED 42 0.0069
397 HYPOCALCAEMIA 98 0.0069
398 GAIT INABILITY 132 0.0068
399 WALKING AID USER 32 0.0068
400 SHOCK 115 0.0068
401 EPSTEIN-BARR VIRUS INFECTION 31 0.0067
402 JAUNDICE 153 0.0067
403 DISORIENTATION 221 0.0067
404 PAPULE 29 0.0067
405 HYPERCHOLESTEROLAEMIA 42 0.0067
406 PERICARDIAL EFFUSION 114 0.0066
407 ANAEMIA 996 0.0066
408 ELECTROLYTE IMBALANCE 55 0.0066
409 ATRIAL FLUTTER 43 0.0066
410 MUSCULAR WEAKNESS 576 0.0066
411 LOWER GASTROINTESTINAL HAEMORRHAGE 42 0.0065
412 MYOPATHY 44 0.0065
413 HEPATIC FAILURE 158 0.0065
414 MITRAL VALVE INCOMPETENCE 59 0.0065
415 PULMONARY MASS 70 0.0065
416 MYALGIA 850 0.0064
417 RETINAL HAEMORRHAGE 36 0.0064
418 BRAIN OEDEMA 63 0.0064
419 BLOOD MAGNESIUM DECREASED 40 0.0064
420 BRONCHITIS 378 0.0064
421 LYMPHOPENIA 65 0.0064
422 HYPERKALAEMIA 171 0.0064
423 WHITE BLOOD CELL COUNT DECREASED 514 0.0063
424 MUSCULOSKELETAL DISCOMFORT 82 0.0063
425 HYPONATRAEMIA 280 0.0063
426 SKIN LESION 126 0.0063
427 TACHYCARDIA 430 0.0063
428 PULMONARY EMBOLISM 495 0.0062
429 CONSTIPATION 966 0.0062
430 EYE INFLAMMATION 38 0.0062
431 INGUINAL HERNIA 30 0.0062
432 FULL BLOOD COUNT DECREASED 87 0.0062
433 SPINAL OSTEOARTHRITIS 44 0.0062
434 WHITE BLOOD CELL COUNT INCREASED 192 0.0062
435 RESPIRATORY RATE INCREASED 42 0.0062
436 INFECTION 634 0.0062
437 NERVE INJURY 55 0.0062
438 DIFFUSE LARGE B-CELL LYMPHOMA 28 0.0062
439 TINNITUS 218 0.0061
440 DECUBITUS ULCER 40 0.0061
441 VENTRICULAR EXTRASYSTOLES 52 0.0061
442 RENAL FAILURE CHRONIC 47 0.0061
443 DEVICE RELATED INFECTION 78 0.0061
444 MUSCLE TWITCHING 111 0.0061
445 SENSORY DISTURBANCE 82 0.0060
446 PHOTOPHOBIA 82 0.0060
447 MELAENA 108 0.0060
448 SUDDEN DEATH 55 0.0060
449 PNEUMONIA ASPIRATION 113 0.0060
450 BONE MARROW FAILURE 110 0.0060
451 FACIAL PARALYSIS 36 0.0060
452 QUALITY OF LIFE DECREASED 62 0.0060
453 ASTHMA 438 0.0059
454 PSYCHOTIC DISORDER 139 0.0059
455 HAEMARTHROSIS 34 0.0059
456 BRONCHOSPASM 68 0.0059
457 HAEMOLYSIS 36 0.0059
458 RENAL CYST 38 0.0059
459 BLOOD SODIUM DECREASED 85 0.0058
460 EXTRASYSTOLES 34 0.0058
461 MUSCLE STRAIN 39 0.0058
462 MICTURITION URGENCY 50 0.0058
463 TREATMENT FAILURE 323 0.0058
464 MOUTH HAEMORRHAGE 32 0.0058
465 HAEMATURIA 163 0.0058
466 PRESYNCOPE 106 0.0058
467 PANIC ATTACK 165 0.0057
468 ANGIOEDEMA 193 0.0057
469 LIVER DISORDER 189 0.0057
470 AUTOIMMUNE DISORDER 30 0.0057
471 PAIN IN EXTREMITY 1324 0.0057
472 CELLULITIS 227 0.0057
473 RASH ERYTHEMATOUS 178 0.0057
474 MUSCLE RIGIDITY 52 0.0056
475 BODY TEMPERATURE DECREASED 45 0.0056
476 HAEMODIALYSIS 45 0.0056
477 DYSSTASIA 129 0.0056
478 ACIDOSIS 34 0.0056
479 NEPHROTIC SYNDROME 29 0.0056
480 ADRENAL INSUFFICIENCY 41 0.0056
481 IMPAIRED GASTRIC EMPTYING 32 0.0056
482 MUSCULOSKELETAL CHEST PAIN 66 0.0056
483 ADVERSE REACTION 57 0.0056
484 SHOCK HAEMORRHAGIC 33 0.0056
485 EMPHYSEMA 46 0.0055
486 DIARRHOEA HAEMORRHAGIC 40 0.0055
487 CONFUSIONAL STATE 709 0.0055
488 HAEMATOCRIT DECREASED 92 0.0055
489 DYSPNOEA EXERTIONAL 148 0.0055
490 RED BLOOD CELL COUNT DECREASED 117 0.0054
491 DECREASED ACTIVITY 41 0.0054
492 PHARYNGEAL SWELLING 27 0.0054
493 HYPERCALCAEMIA 51 0.0054
494 ATRIAL FIBRILLATION 405 0.0054
495 HAEMOGLOBIN DECREASED 436 0.0054
496 DERMATITIS 76 0.0054
497 RASH PUSTULAR 34 0.0053
498 ARTHRALGIA 1577 0.0053
499 LYMPHADENOPATHY 144 0.0053
500 SPLENOMEGALY 49 0.0053
501 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 218 0.0053
502 TRANSFUSION 44 0.0053
503 TOXICITY TO VARIOUS AGENTS 644 0.0053
504 RIB FRACTURE 84 0.0053
505 WOUND INFECTION 36 0.0053
506 ARRHYTHMIA 203 0.0053
507 MYELOSUPPRESSION 44 0.0053
508 GASTROINTESTINAL INFECTION 34 0.0053
509 BLOOD PRESSURE DIASTOLIC DECREASED 29 0.0052
510 PLATELET COUNT INCREASED 51 0.0052
511 LUNG DISORDER 188 0.0052
512 MYELODYSPLASTIC SYNDROME 60 0.0052
513 PAROSMIA 30 0.0052
514 HYPOTONIA 43 0.0052
515 DERMATITIS ALLERGIC 45 0.0052
516 ABNORMAL FAECES 31 0.0052
517 EPILEPSY 114 0.0052
518 TENDERNESS 43 0.0052
519 RESTLESSNESS 150 0.0052
520 HEPATIC STEATOSIS 73 0.0052
521 OSTEOMYELITIS 77 0.0051
522 DRUG INTOLERANCE 352 0.0051
523 PLASMA CELL MYELOMA 147 0.0051
524 ABSCESS 61 0.0051
525 ABASIA 127 0.0051
526 APHONIA 51 0.0051
527 SUBDURAL HAEMATOMA 61 0.0051
528 HYPERGLYCAEMIA 148 0.0051
529 IMPAIRED QUALITY OF LIFE 43 0.0051
530 OSTEOPOROSIS 167 0.0051
531 INTESTINAL PERFORATION 44 0.0051
532 PANCREATITIS ACUTE 86 0.0051
533 IRON DEFICIENCY ANAEMIA 36 0.0051
534 CONTRAINDICATED PRODUCT ADMINISTERED 103 0.0051
535 HALLUCINATION 277 0.0051
536 PARAESTHESIA ORAL 54 0.0050
537 PARAESTHESIA 616 0.0050
538 GAIT DISTURBANCE 756 0.0050
539 DRUG LEVEL INCREASED 64 0.0050
540 FLUID OVERLOAD 73 0.0050
541 JOINT STIFFNESS 99 0.0050
542 FUNGAL INFECTION 125 0.0050
543 LARGE INTESTINE PERFORATION 27 0.0050
544 OXYGEN SATURATION DECREASED 191 0.0050
545 IMMUNOSUPPRESSION 28 0.0050
546 LIMB DISCOMFORT 115 0.0049
547 JOINT SWELLING 431 0.0049
548 HAEMORRHAGE INTRACRANIAL 63 0.0049
549 GASTRITIS 102 0.0049
550 SECRETION DISCHARGE 40 0.0049
551 ANAPHYLACTIC REACTION 188 0.0049
552 EYELID OEDEMA 50 0.0049
553 OPTIC NEURITIS 36 0.0049
554 UPPER GASTROINTESTINAL HAEMORRHAGE 67 0.0048
555 CONDITION AGGRAVATED 977 0.0048
556 CARDIOMEGALY 52 0.0048
557 LIVER INJURY 67 0.0048
558 INFUSION RELATED REACTION 216 0.0048
559 STOMATITIS 213 0.0048
560 SKIN REACTION 51 0.0048
561 BLOOD POTASSIUM DECREASED 112 0.0048
562 SEROTONIN SYNDROME 66 0.0048
563 TASTE DISORDER 45 0.0048
564 MYOSITIS 30 0.0048
565 BONE DENSITY DECREASED 130 0.0048
566 SMALL INTESTINAL OBSTRUCTION 44 0.0047
567 PULMONARY OEDEMA 167 0.0047
568 LIVER FUNCTION TEST ABNORMAL 121 0.0047
569 LIVER FUNCTION TEST INCREASED 64 0.0047
570 ORAL DISORDER 27 0.0047
571 URINARY TRACT INFECTION 587 0.0047
572 SUBARACHNOID HAEMORRHAGE 37 0.0047
573 FLANK PAIN 34 0.0047
574 NASAL DISCOMFORT 30 0.0047
575 COUGH 939 0.0047
576 NIGHT SWEATS 109 0.0047
577 URINARY RETENTION 119 0.0047
578 CARDIAC FAILURE 287 0.0047
579 HYPOAESTHESIA 542 0.0046
580 DYSPNOEA 2013 0.0046
581 CIRCULATORY COLLAPSE 66 0.0046
582 LIPASE INCREASED 28 0.0046
583 CARDIOMYOPATHY 55 0.0046
584 PHARYNGITIS 45 0.0046
585 DYSPHAGIA 325 0.0046
586 BLOOD CREATINE PHOSPHOKINASE INCREASED 112 0.0046
587 HERPES ZOSTER 200 0.0045
588 SKIN INFECTION 36 0.0045
589 PROTEINURIA 60 0.0045
590 BLADDER DISORDER 36 0.0045
591 COLITIS 116 0.0045
592 SWOLLEN TONGUE 114 0.0045
593 CARDIAC ARREST 301 0.0045
594 DEAFNESS 88 0.0045
595 HEPATOMEGALY 37 0.0045
596 RHINITIS 27 0.0045
597 HALLUCINATION, AUDITORY 54 0.0044
598 CARDIO-RESPIRATORY ARREST 154 0.0044
599 MOVEMENT DISORDER 111 0.0044
600 SKIN HYPERPIGMENTATION 30 0.0044
601 GASTROINTESTINAL DISORDER 244 0.0044
602 ACTIVITIES OF DAILY LIVING IMPAIRED 86 0.0043
603 ASTHENIA 1243 0.0043
604 THROAT TIGHTNESS 91 0.0043
605 GOUT 59 0.0043
606 SEIZURE 339 0.0043
607 BLOOD POTASSIUM INCREASED 55 0.0043
608 BEDRIDDEN 44 0.0043
609 HYPOKINESIA 50 0.0043
610 DECREASED APPETITE 722 0.0043
611 CARDIOVASCULAR DISORDER 97 0.0043
612 OEDEMA PERIPHERAL 437 0.0043
613 CHROMATURIA 77 0.0042
614 MUSCULOSKELETAL STIFFNESS 279 0.0042
615 CONJUNCTIVITIS 51 0.0042
616 PULMONARY HYPERTENSION 72 0.0042
617 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 75 0.0042
618 SWELLING 293 0.0042
619 HYPOTHYROIDISM 96 0.0042
620 PULMONARY THROMBOSIS 34 0.0042
621 LOWER RESPIRATORY TRACT INFECTION 130 0.0042
622 DISEASE RECURRENCE 112 0.0042
623 BLOOD PRESSURE SYSTOLIC INCREASED 60 0.0042
624 OSTEOARTHRITIS 133 0.0042
625 SKIN ULCER 84 0.0042
626 IMMUNODEFICIENCY 38 0.0042
627 RETINAL DETACHMENT 29 0.0042
628 THROMBOSIS 266 0.0042
629 BLISTER 170 0.0041
630 HEPATIC CIRRHOSIS 56 0.0041
631 ANXIETY 939 0.0041
632 GENERAL PHYSICAL HEALTH DETERIORATION 323 0.0041
633 FALL 1050 0.0041
634 DRUG TOXICITY 56 0.0041
635 CEREBRAL HAEMORRHAGE 117 0.0041
636 DYSPHONIA 178 0.0041
637 DISTURBANCE IN ATTENTION 176 0.0041
638 NECK PAIN 173 0.0041
639 ANAPHYLACTIC SHOCK 75 0.0041
640 LOCALISED INFECTION 74 0.0041
641 INFLAMMATION 141 0.0041
642 SINUS DISORDER 60 0.0041
643 MYOCARDITIS 28 0.0040
644 JOINT INJURY 65 0.0040
645 DEHYDRATION 425 0.0040
646 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 27 0.0040
647 CYSTITIS 103 0.0040
648 AGITATION 244 0.0040
649 ASCITES 92 0.0040
650 PHOTOSENSITIVITY REACTION 51 0.0040
651 DYSURIA 117 0.0040
652 APHASIA 95 0.0039
653 PAIN 1880 0.0039
654 PRURITUS GENERALISED 85 0.0039
655 SEASONAL ALLERGY 35 0.0039
656 CEREBRAL INFARCTION 77 0.0039
657 VOMITING 1383 0.0039
658 RASH 1226 0.0039
659 URTICARIA 477 0.0039
660 SINUS BRADYCARDIA 30 0.0039
661 LEUKAEMIA 28 0.0039
662 EAR DISCOMFORT 29 0.0039
663 UNRESPONSIVE TO STIMULI 77 0.0039
664 BURNING SENSATION 213 0.0038
665 MOUTH ULCERATION 59 0.0038
666 DIARRHOEA 1800 0.0038
667 HYPOPHAGIA 72 0.0038
668 RENAL DISORDER 138 0.0038
669 CORONARY ARTERY DISEASE 105 0.0038
670 VIRAL INFECTION 90 0.0038
671 UVEITIS 33 0.0038
672 BODY TEMPERATURE INCREASED 63 0.0038
673 VITAMIN D DEFICIENCY 28 0.0038
674 VISUAL IMPAIRMENT 335 0.0038
675 GASTROINTESTINAL HAEMORRHAGE 275 0.0038
676 CHILLS 342 0.0038
677 SARS-COV-2 TEST POSITIVE 31 0.0038
678 GRAND MAL CONVULSION 35 0.0038
679 CHEST DISCOMFORT 288 0.0038
680 LOCAL SWELLING 66 0.0038
681 PSYCHOMOTOR HYPERACTIVITY 53 0.0038
682 FIBROMYALGIA 64 0.0037
683 MENTAL DISORDER 126 0.0037
684 DISEASE PROGRESSION 302 0.0037
685 SINUSITIS 284 0.0037
686 RENAL PAIN 30 0.0037
687 EPISTAXIS 218 0.0037
688 DELUSION 43 0.0037
689 JOINT DISLOCATION 29 0.0037
690 DEEP VEIN THROMBOSIS 206 0.0037
691 DIALYSIS 43 0.0037
692 ERYTHEMA 579 0.0037
693 VISUAL ACUITY REDUCED 110 0.0036
694 ANKLE FRACTURE 44 0.0036
695 RASH GENERALISED 94 0.0036
696 ATAXIA 35 0.0036
697 FAECES DISCOLOURED 62 0.0036
698 FOOT DEFORMITY 30 0.0036
699 RASH PRURITIC 140 0.0036
700 TOOTH LOSS 61 0.0036
701 SLEEP DISORDER 175 0.0036
702 DYSKINESIA 114 0.0036
703 HEPATIC ENZYME INCREASED 173 0.0035
704 INSOMNIA 749 0.0035
705 POOR QUALITY SLEEP 55 0.0035
706 MUSCLE SPASMS 505 0.0035
707 BONE PAIN 161 0.0035
708 LACTIC ACIDOSIS 78 0.0035
709 INFLUENZA 263 0.0035
710 TREMOR 467 0.0035
711 ACUTE MYOCARDIAL INFARCTION 87 0.0035
712 DEPRESSION 660 0.0035
713 COLD SWEAT 49 0.0035
714 BACK PAIN 629 0.0035
715 SPINAL PAIN 30 0.0035
716 BLOOD TEST ABNORMAL 34 0.0035
717 SYNCOPE 276 0.0035
718 PULMONARY CONGESTION 35 0.0035
719 EAR PAIN 51 0.0035
720 GLOMERULAR FILTRATION RATE DECREASED 27 0.0035
721 BLOOD PRESSURE DECREASED 177 0.0034
722 EAR INFECTION 62 0.0034
723 HAEMORRHOIDS 53 0.0034
724 PALPITATIONS 310 0.0034
725 ARTHROPATHY 144 0.0034
726 LIP SWELLING 88 0.0034
727 EATING DISORDER 57 0.0034
728 PALLOR 67 0.0034
729 SOPOR 39 0.0034
730 CYANOSIS 43 0.0034
731 MYOCARDIAL ISCHAEMIA 34 0.0034
732 CATARACT 143 0.0034
733 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 120 0.0034
734 CHOLECYSTITIS 31 0.0034
735 SPINAL FRACTURE 49 0.0033
736 SKIN DISORDER 78 0.0033
737 OFF LABEL USE 1715 0.0033
738 GINGIVAL BLEEDING 33 0.0033
739 ABDOMINAL PAIN 590 0.0033
740 HEART RATE IRREGULAR 63 0.0033
741 DYSARTHRIA 100 0.0033
742 HYPERTENSION 532 0.0033
743 NIGHTMARE 93 0.0033
744 DIVERTICULITIS 69 0.0033
745 PERITONITIS 56 0.0033
746 EJECTION FRACTION DECREASED 39 0.0033
747 HYPERSENSITIVITY 466 0.0033
748 HYPERLIPIDAEMIA 33 0.0033
749 NAUSEA 1957 0.0033
750 HAEMATEMESIS 67 0.0033
751 MUSCULOSKELETAL DISORDER 50 0.0032
752 PERIPHERAL SWELLING 351 0.0032
753 FATIGUE 1854 0.0032
754 ORAL PAIN 57 0.0032
755 SINUS CONGESTION 33 0.0032
756 FOOT FRACTURE 48 0.0032
757 INTERNAL HAEMORRHAGE 29 0.0032
758 PAIN IN JAW 73 0.0032
759 PARALYSIS 36 0.0032
760 HYPERHIDROSIS 321 0.0032
761 CARDIAC FAILURE CONGESTIVE 228 0.0031
762 HEART RATE INCREASED 237 0.0031
763 GASTRIC HAEMORRHAGE 31 0.0031
764 THERAPY INTERRUPTED 71 0.0031
765 RETCHING 50 0.0031
766 PRURITUS 783 0.0031
767 INTERVERTEBRAL DISC PROTRUSION 55 0.0031
768 PRODUCT USE IN UNAPPROVED INDICATION 452 0.0031
769 AGEUSIA 60 0.0031
770 TOOTH FRACTURE 27 0.0031
771 COORDINATION ABNORMAL 37 0.0031
772 BRADYCARDIA 130 0.0031
773 EMOTIONAL DISTRESS 326 0.0030
774 HEMIPARESIS 43 0.0030
775 DYSPEPSIA 223 0.0030
776 METASTASES TO BONE 34 0.0030
777 CHEST PAIN 450 0.0030
778 BACK DISORDER 38 0.0030
779 DIPLOPIA 59 0.0030
780 WRIST FRACTURE 28 0.0030
781 INTENTIONAL PRODUCT USE ISSUE 170 0.0030
782 URINARY INCONTINENCE 70 0.0030
783 LOSS OF CONSCIOUSNESS 304 0.0030
784 LETHARGY 137 0.0030
785 OROPHARYNGEAL PAIN 203 0.0030
786 ADVERSE DRUG REACTION 177 0.0030
787 COMA 111 0.0030
788 DISABILITY 45 0.0029
789 ANGINA PECTORIS 71 0.0029
790 PERICARDITIS 28 0.0029
791 POST PROCEDURAL HAEMORRHAGE 28 0.0029
792 VISION BLURRED 301 0.0029
793 HAEMATOCHEZIA 114 0.0029
794 ORAL DISCOMFORT 32 0.0029
795 UPPER LIMB FRACTURE 48 0.0029
796 FLUID RETENTION 117 0.0029
797 PHARYNGEAL OEDEMA 44 0.0029
798 DRY EYE 84 0.0029
799 FEELING COLD 63 0.0029
800 LYMPHOMA 35 0.0029
801 IMMUNE SYSTEM DISORDER 28 0.0029
802 MASS 32 0.0029
803 FEAR 68 0.0029
804 NO THERAPEUTIC RESPONSE 35 0.0029
805 RASH PAPULAR 52 0.0029
806 HAEMORRHAGE 222 0.0028
807 BONE LOSS 36 0.0028
808 SPEECH DISORDER 118 0.0028
809 MALIGNANT NEOPLASM PROGRESSION 202 0.0028
810 GASTRIC DISORDER 91 0.0028
811 MANIA 37 0.0028
812 HEAD DISCOMFORT 35 0.0028
813 ABDOMINAL PAIN UPPER 427 0.0028
814 RECTAL HAEMORRHAGE 95 0.0028
815 THERAPY NON-RESPONDER 73 0.0028
816 BONE DISORDER 43 0.0028
817 LIMB INJURY 53 0.0027
818 SLEEP APNOEA SYNDROME 43 0.0027
819 RASH MACULAR 69 0.0027
820 PRESCRIBED OVERDOSE 40 0.0027
821 KIDNEY INFECTION 40 0.0027
822 POST PROCEDURAL COMPLICATION 42 0.0027
823 VERTIGO 131 0.0027
824 MEDICATION ERROR 118 0.0027
825 ARTHRITIS 158 0.0027
826 MYDRIASIS 27 0.0027
827 DIZZINESS 1026 0.0027
828 WEIGHT DECREASED 567 0.0027
829 ECZEMA 56 0.0027
830 LABORATORY TEST ABNORMAL 59 0.0027
831 GASTROENTERITIS VIRAL 34 0.0026
832 ISCHAEMIC STROKE 38 0.0026
833 LOWER LIMB FRACTURE 35 0.0026
834 PELVIC PAIN 38 0.0026
835 CONTUSION 191 0.0026
836 OCULAR HYPERAEMIA 82 0.0026
837 MIDDLE INSOMNIA 35 0.0026
838 POLLAKIURIA 82 0.0025
839 BLOOD PRESSURE ABNORMAL 35 0.0025
840 CHOLELITHIASIS 66 0.0025
841 SKIN EXFOLIATION 149 0.0025
842 GASTRIC ULCER 39 0.0025
843 TREATMENT NONCOMPLIANCE 94 0.0025
844 SWELLING FACE 127 0.0025
845 HOSPITALISATION 251 0.0025
846 MOOD ALTERED 53 0.0025
847 ANOREXIA 32 0.0025
848 THINKING ABNORMAL 39 0.0025
849 MEMORY IMPAIRMENT 263 0.0025
850 ABDOMINAL DISCOMFORT 304 0.0025
851 HIP FRACTURE 60 0.0025
852 RHINORRHOEA 113 0.0025
853 ABDOMINAL DISTENSION 190 0.0024
854 EYE PAIN 93 0.0024
855 MULTIPLE FRACTURES 34 0.0024
856 SKIN DISCOLOURATION 87 0.0024
857 COVID-19 209 0.0024
858 NERVOUSNESS 108 0.0024
859 BLOOD URINE PRESENT 37 0.0024
860 PARANOIA 34 0.0024
861 PRODUCT PRESCRIBING ERROR 33 0.0024
862 NEPHROLITHIASIS 80 0.0024
863 TRANSIENT ISCHAEMIC ATTACK 67 0.0024
864 HEART RATE DECREASED 66 0.0024
865 NEOPLASM PROGRESSION 62 0.0024
866 LACRIMATION INCREASED 49 0.0024
867 EYE DISORDER 58 0.0024
868 MENTAL IMPAIRMENT 45 0.0023
869 RHEUMATOID ARTHRITIS 193 0.0023
870 AMNESIA 125 0.0023
871 MALAISE 819 0.0023
872 DISCOMFORT 94 0.0023
873 DYSGEUSIA 139 0.0023
874 CONVULSION 133 0.0023
875 BLOOD PRESSURE INCREASED 273 0.0023
876 OSTEONECROSIS 67 0.0023
877 ANOSMIA 26 0.0023
878 BLOOD PRESSURE FLUCTUATION 43 0.0023
879 BASAL CELL CARCINOMA 27 0.0023
880 ABDOMINAL PAIN LOWER 45 0.0022
881 RESPIRATORY ARREST 54 0.0022
882 HEADACHE 1074 0.0022
883 HYPOACUSIS 66 0.0022
884 FREQUENT BOWEL MOVEMENTS 38 0.0022
885 CARDIAC DISORDER 164 0.0022
886 CENTRAL NERVOUS SYSTEM LESION 26 0.0022
887 NASOPHARYNGITIS 281 0.0022
888 METASTASES TO LIVER 28 0.0022
889 ORAL HERPES 29 0.0022
890 DRY MOUTH 130 0.0021
891 BLINDNESS 64 0.0021
892 ILLNESS 73 0.0021
893 UNEVALUABLE EVENT 130 0.0021
894 ALOPECIA 327 0.0021
895 TOOTHACHE 29 0.0021
896 HERNIA 29 0.0021
897 IMPAIRED HEALING 50 0.0021
898 INCORRECT PRODUCT ADMINISTRATION DURATION 27 0.0021
899 DEMENTIA 40 0.0021
900 ABORTION SPONTANEOUS 67 0.0020
901 SOMNOLENCE 319 0.0020
902 AGGRESSION 85 0.0020
903 BLOOD GLUCOSE ABNORMAL 29 0.0020
904 DIABETES MELLITUS 124 0.0020
905 FRACTURE 30 0.0020
906 DEATH 1257 0.0020
907 PRODUCT DOSE OMISSION 130 0.0020
908 EXTRAPYRAMIDAL DISORDER 44 0.0019
909 WOUND 36 0.0019
910 NASAL CONGESTION 79 0.0019
911 SURGERY 74 0.0019
912 INTESTINAL OBSTRUCTION 52 0.0019
913 GLAUCOMA 29 0.0019
914 ILL-DEFINED DISORDER 61 0.0019
915 SUICIDAL IDEATION 140 0.0019
916 TYPE 2 DIABETES MELLITUS 50 0.0019
917 INJURY 115 0.0019
918 RESTLESS LEGS SYNDROME 27 0.0019
919 DEPRESSED MOOD 73 0.0019
920 FLATULENCE 79 0.0019
921 DRUG INEFFECTIVE 1802 0.0018
922 EYE SWELLING 51 0.0018
923 BLOOD TRIGLYCERIDES INCREASED 26 0.0018
924 DRUG PRESCRIBING ERROR 34 0.0018
925 CRYING 54 0.0018
926 FEELING HOT 81 0.0018
927 HYPERSOMNIA 38 0.0018
928 FEELING ABNORMAL 337 0.0017
929 HEAD INJURY 41 0.0017
930 PSORIASIS 162 0.0017
931 ABNORMAL BEHAVIOUR 58 0.0017
932 PANCREATITIS 70 0.0017
933 SYSTEMIC LUPUS ERYTHEMATOSUS 36 0.0016
934 INFLUENZA LIKE ILLNESS 107 0.0016
935 THROAT IRRITATION 51 0.0016
936 PRODUCT USE ISSUE 207 0.0015
937 STRESS 79 0.0015
938 MOOD SWINGS 40 0.0015
939 WEIGHT INCREASED 251 0.0015
940 FLUSHING 126 0.0015
941 THERAPY CESSATION 53 0.0015
942 DRY SKIN 132 0.0014
943 OSTEONECROSIS OF JAW 31 0.0014
944 EXPOSURE DURING PREGNANCY 64 0.0014
945 MYOCARDIAL INFARCTION 219 0.0014
946 PRODUCT DOSE OMISSION ISSUE 155 0.0014
947 PREMATURE BABY 34 0.0014
948 MIGRAINE 96 0.0014
949 GASTRIC CANCER 31 0.0014
950 HOT FLUSH 74 0.0014
951 THERAPEUTIC PRODUCT EFFECT DECREASED 36 0.0014
952 ABNORMAL DREAMS 33 0.0014
953 FEMUR FRACTURE 36 0.0014
954 THERAPEUTIC RESPONSE DECREASED 55 0.0012
955 ADVERSE EVENT 86 0.0012
956 BLOOD GLUCOSE DECREASED 47 0.0012
957 LUNG NEOPLASM MALIGNANT 41 0.0012
958 DRUG EFFECT INCOMPLETE 42 0.0012
959 ROAD TRAFFIC ACCIDENT 37 0.0011
960 PSORIATIC ARTHROPATHY 27 0.0011
961 COLITIS ULCERATIVE 30 0.0011
962 ANGER 32 0.0011
963 DRUG ABUSE 71 0.0011
964 EMOTIONAL DISORDER 28 0.0011
965 CEREBROVASCULAR ACCIDENT 155 0.0011
966 NEOPLASM MALIGNANT 54 0.0011
967 INCORRECT DRUG ADMINISTRATION DURATION 30 0.0011
968 IRRITABILITY 52 0.0010
969 INTENTIONAL PRODUCT MISUSE 68 0.0010
970 MATERNAL EXPOSURE DURING PREGNANCY 59 0.0010
971 OVERDOSE 172 0.0010
972 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 87 0.0010
973 INCORRECT DOSE ADMINISTERED 135 0.0010
974 BLOOD GLUCOSE INCREASED 152 0.0010
975 DRUG DOSE OMISSION 156 0.0009
976 WITHDRAWAL SYNDROME 28 0.0009
977 VAGINAL HAEMORRHAGE 33 0.0009
978 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0009
979 SKIN BURNING SENSATION 50 0.0009
980 MULTIPLE SCLEROSIS RELAPSE 51 0.0009
981 SUICIDE ATTEMPT 40 0.0008
982 BLOOD CHOLESTEROL INCREASED 29 0.0008
983 EYE IRRITATION 30 0.0008
984 FOETAL EXPOSURE DURING PREGNANCY 49 0.0008
985 MULTIPLE SCLEROSIS 29 0.0008
986 INJECTION SITE PRURITUS 36 0.0007
987 UNDERDOSE 40 0.0007
988 ACNE 41 0.0007
989 NO ADVERSE EVENT 71 0.0007
990 PROSTATE CANCER 47 0.0006
991 INJECTION SITE ERYTHEMA 56 0.0006
992 COMPLETED SUICIDE 37 0.0005
993 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 36 0.0005
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 68 0.0005
995 INJECTION SITE PAIN 87 0.0004
996 PRODUCT QUALITY ISSUE 46 0.0004
997 DRUG WITHDRAWAL SYNDROME 31 0.0004
998 DRUG DEPENDENCE 54 0.0004
999 BREAST CANCER 26 0.0003